动态胸部X线摄影评估囊性纤维化患者肺动脉加重治疗的研究
这项前瞻性、观察性、单中心初步研究纳入20例囊性纤维化患者,在肺动脉加重治疗前后分别进行肺量计检查和动态胸部X线摄影。治疗后FEV1占预计值百分比中位数从44%升至55%(P=0.004),动态胸部X线摄影显示左右半膈深呼吸移动度及呼气速度、潮式呼吸时投影肺面积变化均改善。
要点
- 动态胸部X线摄影可测量半膈移动度、呼气速度和投影肺面积变化,用于评估囊性纤维化肺动脉加重治疗后的肺力学改善。
- 治疗后FEV1占预计值百分比中位数从44%升至55%(P=0.004),与动态胸部X线摄影指标改善方向一致。
- 动态胸部X线摄影可能作为肺量计检查的补充工具,用于无法配合用力呼气患者的肺力学评估。
核心结论
- 动态胸部X线摄影显示囊性纤维化患者肺动脉加重治疗后膈肌速度和胸壁运动范围改善,并显示出作为研究肺动脉加重对肺力学影响的工具的潜力。
研究设计与样本
- 前瞻性、观察性、单中心初步研究,纳入20例囊性纤维化患者(平均年龄25岁±7[标准差],14例女性),在2019年12月至2020年8月期间于肺动脉加重治疗前后分别进行肺量计检查和动态胸部X线摄影。
关键影像表现/征象
- 动态胸部X线摄影测量投影肺面积、半膈中点位置及潮式呼吸和深呼吸时的速度。
- 治疗后左半膈深呼吸移动度中位数从18 mm(IQR 11)增至25 mm(IQR 16)(P=0.03)。
- 治疗后右半膈深呼吸移动度中位数从13 mm(IQR 6)增至19 mm(IQR 14)(P=0.03)。
- 治疗后左半膈深呼吸后呼气速度中位数从7 mm/秒(IQR 2)增至11 mm/秒(IQR 5)(P=0.004)。
- 治疗后右半膈深呼吸后呼气速度中位数从6 mm/秒(IQR 3)增至9 mm/秒(IQR 6)(P=0.004)。
诊断标准与关键数值
- 肺量计检查测量FEV1和用力肺活量;治疗后FEV1占预计值百分比中位数从44%(IQR 17%)升至55%(IQR 16%)(P=0.004)。
- 动态胸部X线摄影测量完全呼气时投影肺面积变化率均值从42 cm²/秒±16增至56 cm²/秒±24(P=0.03)。
- 动态胸部X线摄影测量潮式呼吸时投影肺面积变化均值从29 cm²±14增至35 cm²±10(P=0.03)。
临床应用与阅片要点
- 动态胸部X线摄影可提供实时肺动力学信息及透视风格胸部影像,作为肺量计检查的补充。
- 对于无法配合用力呼气肺量计检查的患者,动态胸部X线摄影可能有助于评估肺动脉加重治疗后的肺力学变化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Although spirometry is an important marker in the management of pulmonary exacerbations in cystic fibrosis (CF), it is a forced maneuver and can generate aerosol. Therefore, it may be difficult to perform in some individuals. Dynamic chest radiography (DCR) provides real-time information regarding pulmonary dynamics alongside fluoroscopic-style thoracic imaging. Purpose To assess the effect of pulmonary exacerbation treatment by using both spirometry and DCR and assess the clinical utility of DCR in participants with CF experiencing pulmonary exacerbations. Materials and Methods In this prospective, observational, single-center pilot study, spirometry and DCR were performed before and after treatment of pulmonary exacerbations in participants with CF between December 2019 and August 2020. Spirometry measured forced expiratory volume in 1 second (FEV1) and forced vital capacity. DCR helped to measure projected lung area (PLA), hemidiaphragm midpoint position, and speed during tidal and deep breathing. Data were analyzed by using the paired t test or Wilcoxon signed-rank test. Correlation was assessed by using the Spearman rank correlation coefficient. Results Twenty participants with CF (mean age, 25 years ± 7 [standard deviation]; 14 women) were evaluated. Spirometry showed that percentage predicted FEV1 improved from a median of 44% (interquartile range [IQR], 17%) before treatment to 55% (IQR, 16%) after treatment (P = .004). DCR showed improvement in median deep breathing excursion for left and right hemidiaphragms (from 18 [IQR, 11] to 25 [IQR, 16] mm [P = .03] and from 13 [IQR, 6] to 19 [IQR, 14] mm [P = .03], respectively) and in median expiratory speed following deep breathing for left and right hemidiaphragms (from 7 [IQR, 2] to 11 [IQR, 5] mm/sec [P = .004] and 6 [IQR, 3] to 9 [IQR, 6] mm/sec [P = .004], respectively). PLA rate of change during full expiration and change in PLA during tidal breathing improved (from a mean of 42 cm2/sec ± 16 to 56 cm2/sec ± 24 [P = .03] and from a mean of 29 cm2 ± 14 to 35 cm2 ± 10 [P = .03], respectively). Conclusion Dynamic chest radiography demonstrated improvement in diaphragm speed and range of chest wall movement during respiration aftere treatment for pulmonary exacerbations in cystic fibrosis and showed potential as a tool to investigate the effect of pulmonary exacerbations on lung mechanics. Clinical trials registration no. NCT01234567 Published under a CC BY 4.0 license. Online supplemental material is available for this article.
引用
- FitzMaurice, McCann, Nazareth, et al. Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic Fibrosis. Radiology. 2022. PMID: 35289662. doi:10.1148/radiol.212641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。